Find clinical trials for Non-Small-Cell Lung Cancer in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Birmingham, AL, USA:
with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...
Phase 2
Birmingham, Alabama, United States and 49 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...
Phase 1
Birmingham, Alabama, United States and 25 other locations
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T Syst-...
Phase 2
Birmingham, Alabama, United States of America and 23 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Birmingham, Alabama, United States and 291 other locations
This study will evaluate REGN5093 for the treatment of Non-Small Cell Lung Cancer (NSCLC) with MET alter...
Phase 1, Phase 2
Birmingham, Alabama, United States and 29 other locations
study population comprises adults with either advanced/metastatic non-small cell lung cancer (NSCLC) wit...
Phase 1, Phase 2
Birmingham, Alabama, United States and 38 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
Birmingham, Alabama, United States and 57 other locations
adaptive radiotherapy with concomitant chemotherapy for stage III non-small cell lung cancer (NSCLC) wil...
Birmingham, Alabama, United States
and platinum-based chemotherapy for patients with advanced non-small cell lung cancer that has spread to...
Phase 3
Birmingham, Alabama, United States of America and 65 other locations
in combination with chemotherapy in metastatic NSCLC patients with non-squamous histology who have mutations and/or co-mutations in STK11, K...
Phase 3
Birmingham, Alabama, United States and 97 other locations
Clinical trials
Research sites
Resources
Legal